Clincosm LogoSign in Get a demo

melanoma

Showing NaN - NaN of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Boston (Bevacizumab Plus Ipilimumab Cohort 1, Bevacizumab Plus Ipilimumab Cohort 2, Bevacizumab Plus

Active, not recruiting
  • Melanoma
  • Bevacizumab Plus Ipilimumab Cohort 1
  • +3 more
  • Boston, Massachusetts
  • +2 more
Nov 8, 2021

Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 1, 2021

Utility of Novel BRAF Test for Melanoma

Active, not recruiting
  • Melanoma
    • Boston, Massachusetts
    • +2 more
    Oct 28, 2021

    Melanoma, Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in United States (NT-I7, atezolizumab)

    Recruiting
    • Melanoma
    • +2 more
    • Duarte, California
    • +7 more
    Oct 21, 2021

    Brain Cancer, Brain Metastases, Melanoma Trial in Boston (radiation, drug, other)

    Recruiting
    • Brain Cancer
    • +15 more
    • Stereotactic Radiation
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    Melanoma Trial in United States (Ipilimumab, Nivolumab)

    Completed
    Has Results
    • Melanoma
    • Duarte, California
    • +35 more
    Sep 8, 2021

    Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

    Completed
    • Melanoma
    • +3 more
    • Enoblituzumab
    • +2 more
    • Scottsdale, Arizona
    • +19 more
    Sep 22, 2021

    Melanoma, Metastatic Melanoma Trial in Boston (Ipilimumab, Nivolumab, Troriluzole)

    Recruiting
    • Melanoma
    • Metastatic Melanoma
    • Boston, Massachusetts
    • +1 more
    Sep 17, 2021

    Melanoma Trial in Worldwide (nivolumab, ipilimumab)

    Completed
    Has Results
    • Melanoma
    • nivolumab
    • ipilimumab
    • Tucson, Arizona
    • +123 more
    Aug 24, 2021

    Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

    Completed
    • Clear Cell Renal Cell Carcinoma (ccRCC)
    • +2 more
    • Scottsdale, Arizona
    • +16 more
    Aug 16, 2021

    Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

    Completed
    Has Results
    • Triple Negative Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +19 more
    Jul 12, 2021

    Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)

    Recruiting
    • Solid Tumor
    • +2 more
    • T3011
    • T3011 + pembrolizumab
    • Gilbert, Arizona
    • +7 more
    Jun 22, 2021

    Melanoma, Unresectable (Stage III) Melanoma, Metastatic (Stage IV) Melanoma Trial in United States (Omaveloxolone Capsules (2.5

    Completed
    Has Results
    • Melanoma
    • +2 more
    • Omaveloxolone Capsules (2.5 mg/capsule)
    • +4 more
    • Mobile, Alabama
    • +9 more
    Jun 4, 2021

    Adenoid Cystic Carcinoma, Squamous Cell Carcinoma, Sinonasal Carcinoma Trial in Boston, Rochester (Proton radiation therapy,

    Recruiting
    • Adenoid Cystic Carcinoma
    • +8 more
    • Proton radiation therapy
    • Intensity-modulated radiotherapy
    • Boston, Massachusetts
    • +1 more
    Jun 2, 2021

    Melanoma Trial in United States (TAK-580, TAK-202, vedolizumab)

    Terminated
    Has Results
    • Melanoma
    • Tucson, Arizona
    • +13 more
    Mar 3, 2021

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)

    Completed
    • Advanced Malignancy
    • +6 more
    • AMG 232
    • +2 more
    • Los Angeles, California
    • +6 more
    Mar 24, 2021

    Melanoma Trial in Worldwide (Nivolumab, Ipilimumab)

    Withdrawn
    • Melanoma
    • Nivolumab
    • Ipilimumab
    • Gilbert, Arizona
    • +117 more
    Mar 17, 2021

    Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

    Terminated
    Has Results
    • Melanoma
    • GSK 2132231A
    • Placebo
    • Birmingham, Alabama
    • +256 more
    Feb 5, 2021

    Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)

    Completed
    • Sarcoma, Clear Cell
    • +3 more
    • GVAX
    • Boston, Massachusetts
    • +1 more
    Mar 2, 2021

    Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

    Completed
    Has Results
    • Melanoma
    • Scottsdale, Arizona
    • +120 more
    Feb 8, 2021

    Breast Cancer, NSCLC, Melanoma Trial in Worldwide (Abemaciclib)

    Completed
    Has Results
    • Breast Cancer
    • +3 more
    • Duarte, California
    • +43 more
    Dec 17, 2020

    Urothelial Carcinoma, Head Neck Cancer, Melanoma Trial in Canada, Spain, United States (Autologous genetically modified MAGE

    Completed
    • Urothelial Carcinoma
    • +3 more
    • Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells
    • Boston, Massachusetts
    • +10 more
    Dec 17, 2020

    Melanoma Trial in Boston (Poly-ICLC, Peptides)

    Completed
    • Melanoma
    • Poly-ICLC
    • Peptides
    • Boston, Massachusetts
    • +1 more
    Dec 7, 2020

    B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

    Completed
    • B-cell Malignancies
    • +7 more
    • Nivolumab (Phase 1)
    • +4 more
    • Birmingham, Alabama
    • +23 more
    Aug 26, 2020

    Melanoma Trial in Worldwide (pembrolizumab + epacadostat, pembrolizumab + )

    Completed
    Has Results
    • Melanoma
    • pembrolizumab + epacadostat
    • pembrolizumab + placebo
    • Birmingham, Alabama
    • +128 more
    Aug 14, 2020